Tomáš Páleníček
NUDZ, Prague, Czech Republic
Czech Psilocybin Law | PSY-NET COST Action
Pedro Mediano
Imperial College London, UK
A unifying framework for the large-scale neuroscience of psychedelics
Eyal Kurzbaum
Shamir Research Institute, University of Haifa, Israel
From Fruiting Bodies to Mycelium: Tryptamine Variability in Psilocybe cubensis
Jaroslav Hlinka
NUDZ | Institute of Computer Science, Czech Academy of Sciences
Do we need complexity? Nonlinear and higher-order interactions in brain connectivity
Romanos K. Antonopoulos
National and Kapodistrian University of Athens, Greece
Psychedelic Eleusis: From the ancestral pharmakon to modern medicine
Philippe De Deurwaerdère
University of Bordeaux, France
The Psy-Net COST Action: Purpose and Expectations
Dimitris Repantis
Charité — Universitätsmedizin Berlin, Germany
Ethical issues in psychedelic-assisted therapy
Patrick Fisher
University of Copenhagen, Denmark
Psychedelics distinctly alter brain entropy and complexity compared to psychostimulants
Helena Aicher
University of Zurich, Switzerland
Psychedelic-Assisted Therapy in the Swiss Limited Medical Use Program
Ines Erkizia-Santamaria
Universidade de Lisboa, PT | University of the Basque Country, ES
Endogenous serotonin modulates psychedelic-like effects of psilocybin in mice
Joanna Kuc
University College London (UCL), UK
Speech-based experience sampling in psychedelic research
Giovanni Rabuffo
University College London (UCL), UK
Frequency-Resolved Reorganization of the Brain's Functional Repertoire under DMT
Marek Nikolić
Psychedelic Research Center, NUDZ | Charles University, Prague
Biomarkers of Acute and Persisting Effects in Healthy Subjects Treated with Psilocybin
Zeus Tipado
Maastricht University, Netherlands
Quantifying DMT visual hallucinations using the TRIPADO scale
Adam Wojtas
Maj Institute of Pharmacology, Polish Academy of Sciences, Poland
When psilocybin meets a stressed brain: altered receptor signaling reshapes neurotransmitter release
